Certified by Founder Lodge
Viking Global Investors
United States - Greenwich, Connecticut
INVESTOR
1 Disclosed Funding Rounds $401,000,000
27 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Viking Global Investors LP (“Viking”) is a global investment firm founded in 1999. We employ a fundamentals-driven investment approach to managing over $40 billion of capital across long/sho
| Company | Date | Round | Raised |
|---|---|---|---|
 ID.me |
April, 12 ,2023 | Series D | $132,000,000 |
 Arctic Wolf |
October, 06 ,2022 | Unknown | $401,000,000 |
 Abdera Therapeutics |
April, 24 ,2023 | Series B | $142,000,000 |
 Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
 Solarea Bio |
May, 09 ,2023 | Series B | $15,000,000 |
 AlphaSense |
June, 15 ,2022 | Series D | $225,000,000 |
 Pragma Bio |
March, 27 ,2023 | Unknown | $10,000,000 |
 Lightmatter |
June, 01 ,2023 | Series C | $154,000,000 |
 Global Processing Services |
January, 13 ,2022 | Unknown | $100,000,000 |
 DermBiont, Inc. |
October, 25 ,2023 | Series B | $35,200,000 |
| ID.me |
April, 12 ,2023 | Series D | $132,000,000 |
 Triveni Bio |
October, 27 ,2023 | Series A | $92,000,000 |
| Abdera Therapeutics |
April, 24 ,2023 | Series B | $142,000,000 |
 HI-Bio |
January, 05 ,2024 | Series B | $95,000,000 |
| Solarea Bio |
May, 09 ,2023 | Series B | $15,000,000 |
 Valsoft Corporation |
January, 22 ,2024 | Unknown | $170,000,000 |
| Lightmatter |
June, 01 ,2023 | Series C | $154,000,000 |
 Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
| DermBiont, Inc. |
October, 25 ,2023 | Series B | $35,200,000 |
 Antheia, Inc. |
July, 23 ,2024 | Unknown | $17,000,000 |
| Triveni Bio |
October, 27 ,2023 | Series A | $92,000,000 |
 Metsera |
November, 14 ,2024 | Series B | $215,000,000 |
| HI-Bio |
January, 05 ,2024 | Series B | $95,000,000 |
| Valsoft Corporation |
January, 22 ,2024 | Unknown | $170,000,000 |
| Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
| Antheia, Inc. |
July, 23 ,2024 | Unknown | $17,000,000 |
| Metsera |
November, 14 ,2024 | Series B | $215,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
